首页 | 本学科首页   官方微博 | 高级检索  
检索        

晚期非小细胞肺癌治疗策略
引用本文:李慧杰,齐元富,李秀荣.晚期非小细胞肺癌治疗策略[J].中国肿瘤,2014,23(8):670-673.
作者姓名:李慧杰  齐元富  李秀荣
作者单位:山东中医药大学附属医院;山东中医药大学附属医院;山东中医药大学附属医院
摘    要:肺癌是临床最常见的恶性肿瘤之一,非小细胞肺癌约占肺癌的80%,由于肿瘤具有隐匿性特点,确诊时大约2/3患者已属晚期。随着医学的发展与新药的研发应用,晚期非小细胞肺癌的疗效有所提升,但仍不十分令人满意,临床中急需在一线、二线、维持以及中医药等综合治疗中,逐步优化治疗策略,使患者生存更加获益。

关 键 词:晚期非小细胞肺癌  治疗策略  生存获益
收稿时间:2013/8/27 0:00:00

The Treatment Strategies of Advanced Non-small Cell Lung Cancer
LI Hui-jie,QI Yuan-fu,LI Xiu-rong.The Treatment Strategies of Advanced Non-small Cell Lung Cancer[J].Bulletin of Chinese Cancer,2014,23(8):670-673.
Authors:LI Hui-jie  QI Yuan-fu  LI Xiu-rong
Institution:Affiliated Hospital of Shandong University of Tradition Chinese Medicine
Abstract:Lung cancer is one of the most common cancers,non-small cell lung cancer (NSCLC) accounts for about 80% of lung cancers. Due to the oecuh characteristics,about 2/3 patients were in advanced stage wtlen diagnosed.With the development of medical science amt new drugs application,the response for advanced NSCLC has improved,but not very. satisfaetory. Treatment strategies of first-line,second-line treatments,maintenance therapy, traditional Chinese medicine therapy and comprehensive treatment were urgent to benefit the patients.
Keywords:advanced NSCLC  treatment strategies  survival benefit
本文献已被 维普 等数据库收录!
点击此处可从《中国肿瘤》浏览原始摘要信息
点击此处可从《中国肿瘤》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号